BioSpace News Archive

Danaher Corporation (NYSE: DHR) (“Danaher”) announced today it completed the sale of its label-free biomolecular characterization, chromatography hardware and resins, microcarriers and particle validation standards, single use tangential flow filtration systems, and stainless steel hollow fiber tangential flow filtration systems busines

Research shows that uproleselan is a potent antagonist of E-selectin, can break chemoresistance

In the race to find treatment options for COVID-19 patients, physicians and clinicians began treating the virus as they would viral pneumonia.

Fennec Pharmaceuticals Inc., a specialty pharmaceutical company focused on the development of PEDMARKTM for the prevention of platinum-induced ototoxicity from cisplatin in pediatric cancer patients, announced the pricing of its underwritten public offering of 4,800,000 common shares at a public offering price of $6.25 per share.

Aradigm Corporation (OTC PINK: ARDM) (“Aradigm” or the “Company”) announced on April 27, 2020, the Bankruptcy Court entered an order (i) conditionally approving the disclosure statement for the Combined Chapter 11 Plan and Disclosure Statement (the “Combined Plan”) filed by Aradigm Corporation (the “Company”);

Premier Inc., a leading healthcare improvement company, released new data finding that as COVID-19 cases peak, so does demand for drugs used to treat cardiovascular conditions and blood clots.

CoImmune, Inc. announced that it has successfully completed the merger with Formula Pharmaceuticals, Inc., bringing together two therapeutic immuno-oncology platforms.

New Report From Kitasato Research Center Finds UVC Wavelength Light Effective to Kill Viruses

Acer Therapeutics Inc. announced it has entered into a common stock purchase agreement for up to $15 million with Lincoln Park Capital Fund, LLC, a Chicago-based institutional investor.

Assembly Biosciences, Inc., a clinical-stage biotechnology company developing innovative therapeutics targeting hepatitis B virus and diseases associated with the microbiome, announced plans to host a conference call and live audio webcast on Thursday, May 7, 2020 at 1:30 pm PT / 4:30 pm ET.